BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu H, Han M, Yuan X, Tursun K, Zhang Y, Li Y, Li Z, Feng S, Zhou L, Pan Z, Wang Q, Han K, Liu S, Cheng J. Role of IL-6-mediated expression of NS5ATP9 in autophagy of liver cancer cells. J Cell Physiol 2018;233:9312-9. [PMID: 29227529 DOI: 10.1002/jcp.26343] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Yi M, Wang W, Chen S, Peng Y, Li J, Cai J, Zhou Y, Peng Q, Ban Y, Zeng Z, Li X, Xiong W, Li G, Xiang B. Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6/STAT3 regulatory loop. Mol Biol Rep 2018;45:1277-87. [DOI: 10.1007/s11033-018-4288-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
2 Thongchot S, Jamjuntra P, Therasakvichya S, Warnnissorn M, Ferraresi A, Thuwajit P, Isidoro C, Thuwajit C. Interleukin‑8 released by cancer‑associated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells. Int J Oncol 2021;58:14. [PMID: 33649784 DOI: 10.3892/ijo.2021.5194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Pinto AP, da Rocha AL, Cabrera EMB, Marafon BB, Kohama EB, Rovina RL, Simabuco FM, Bueno Junior CR, de Moura LP, Pauli JR, Cintra DE, Ropelle ER, da Silva ASR. Role of interleukin-6 in inhibiting hepatic autophagy markers in exercised mice. Cytokine 2020;130:155085. [PMID: 32259772 DOI: 10.1016/j.cyto.2020.155085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang Y, Du J, Wu X, Abdelrehem A, Ren Y, Liu C, Zhou X, Wang S. Crosstalk between autophagy and microbiota in cancer progression. Mol Cancer 2021;20:163. [PMID: 34895252 DOI: 10.1186/s12943-021-01461-0] [Reference Citation Analysis]
5 Dang YF, Yang SH, Jiang XN, Gong FL, Yang XX, Cheng YN, Guo XL. Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer. J Drug Target 2021;29:336-48. [PMID: 33115283 DOI: 10.1080/1061186X.2020.1844216] [Reference Citation Analysis]
6 Han LT, Hu JQ, Ma B, Wen D, Zhang TT, Lu ZW, Wei WJ, Wang YL, Wang Y, Liao T, Ji QH. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis. Diagn Pathol 2019;14:52. [PMID: 31159823 DOI: 10.1186/s13000-019-0832-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li L, Yu R, Cai T, Chen Z, Lan M, Zou T, Wang B, Wang Q, Zhao Y, Cai Y. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment. Int Immunopharmacol 2020;88:106939. [PMID: 33182039 DOI: 10.1016/j.intimp.2020.106939] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
8 Cao L, Zhang X, Yuan S, Cheng K, Zhang X. Autophagy induced by enterovirus 71 regulates the production of IL-6 through the p38MAPK and ERK signaling pathways. Microb Pathog 2019;131:120-7. [PMID: 30910719 DOI: 10.1016/j.micpath.2019.03.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Al-Shahari EA, El Barky AR, Mohamed TM, Alm-Eldeen AA. Doxorubicin, L-arginine, or their combination as a prophylactic agent against hepatic carcinoma in mice. Environ Sci Pollut Res Int 2021;28:37661-71. [PMID: 33721166 DOI: 10.1007/s11356-021-13177-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yan Y, Chen X, Wang X, Zhao Z, Hu W, Zeng S, Wei J, Yang X, Qian L, Zhou S, Sun L, Gong Z, Xu Z. The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer. J Exp Clin Cancer Res 2019;38:171. [PMID: 31014370 DOI: 10.1186/s13046-019-1172-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]